Association Between Work-Related Stress and Peripheral Neuropathic Pain in Female Breast Cancer Post CT
NCT ID: NCT07055711
Last Updated: 2025-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
45 participants
OBSERVATIONAL
2025-03-03
2025-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neuropathic Pain in Survivors of Breast Cancer
NCT00535067
Dosimetric Evaluation of Breathing Impact on PTV and Adjacent Organ At Risk in Breast Cancer Radiotherapy
NCT07048639
Biomarkers of Neuropathic Pain in Women Treated for Breast Cancer
NCT02487524
Genetic, Neurophysiological and Psychological Predictive Factors of Chronic Neuropathic Pain After Surgery for Breast Cancer
NCT02944721
Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
NCT07092111
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peripheral Neuropathic Pain
to find out the association between work-related stress and peripheral neuropathic pain in female breast cancer survivors post-chemotherapy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged 29-51.
* Females who is currently employed.
* Females who have done chemotherapy for stage 1,2,3.
* Females who underwent chemotherapy cycles 6-8.
* Females who are willing to participate in the study
Exclusion Criteria
* Females suffering from diabetes.
* Females who have active cancer.
* Females with mastectomy.
* Absent from treatment for more than 2 weeks will be excluded from the study.
21 Years
51 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Superior University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Muhammad Naveed Babur
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lahore City
Lahore, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DPT/Batch-Fall20/1016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.